Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Color Diagnostics, |
RCV001525978 | SCV001736208 | likely pathogenic | Hereditary cancer-predisposing syndrome | 2020-10-13 | criteria provided, single submitter | clinical testing | This variant causes an A to T nucleotide substitution at the -2 position of intron 7 splice acceptor site of the ATM gene. Splice site prediction tools predict that this variant may have a significant impact on RNA splicing. Although this prediction has not been confirmed in published RNA studies, this variant is expected to result in an absent or disrupted protein product. This variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). A different variant affecting the same splice acceptor site, c.902-1G>T, is known to be disease-causing due to its deleterious impact on RNA splicing (Clinvar variation ID: 418911). Loss of ATM function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Likely Pathogenic. |
| Baylor Genetics | RCV003470850 | SCV004212030 | likely pathogenic | Familial cancer of breast | 2023-04-06 | criteria provided, single submitter | clinical testing |